GMO U.S. Value ETF (NYSEARCA:GMOV) Short Interest Update

GMO U.S. Value ETF (NYSEARCA:GMOV) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totaling 13,609 shares, a growth of 219.0% from the May 31st total of 4,266 shares. Currently, 0.5% of the shares of the company are sold short. Based on an average trading volume of 16,719 shares, the days-to-cover ratio is currently 0.8 days.

Institutional Trading of GMO U.S. Value ETF

Several hedge funds have recently added to or reduced their stakes in GMOV. Fifth Third Bancorp acquired a new stake in GMO U.S. Value ETF in the 1st quarter valued at approximately $84,000. Kestra Private Wealth Services LLC bought a new position in GMO U.S. Value ETF in the 1st quarter worth approximately $333,000. Aspen Investment Management Inc acquired a new position in shares of GMO U.S. Value ETF during the fourth quarter worth approximately $333,000. RPS Advisory Solutions LLC acquired a new position in shares of GMO U.S. Value ETF during the fourth quarter worth approximately $484,000. Finally, J.W. Cole Advisors Inc. boosted its position in shares of GMO U.S. Value ETF by 128.7% in the fourth quarter. J.W. Cole Advisors Inc. now owns 28,510 shares of the company’s stock valued at $784,000 after acquiring an additional 16,044 shares during the period.

GMO U.S. Value ETF Stock Down 0.1%

GMOV stock traded down $0.03 during mid-day trading on Monday, reaching $30.14. 28,034 shares of the stock traded hands, compared to its average volume of 15,751. GMO U.S. Value ETF has a 52 week low of $24.79 and a 52 week high of $30.57. The business has a 50-day moving average of $29.83 and a two-hundred day moving average of $28.86. The firm has a market capitalization of $87.41 million, a PE ratio of 12.08 and a beta of 0.64.

About GMO U.S. Value ETF

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.